Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Correction: AB-Amy: machine learning aided amyloidogenic risk prediction of therapeutic antibody light chains

Correction: AB-Amy: machine learning aided amyloidogenic risk prediction of therapeutic antibody... Antibody Therapeutics, 2023, Vol. 6, No. 3 180 https://doi.org/10.1093/abt/tbad012 Advance Access Publication on 26 May 2023 Correction Correction: AB-Amy: machine learning aided amyloidogenic risk prediction of therapeutic antibody light chains This is a correction to: Yuwei Zhou and others, AB-Amy: machine learning aided amyloidogenic risk prediction of therapeutic antibody light chains, Antibody Therapeutics, 2023;, tbad007, https://doi.org/10.1093/abt/tbad007 In the originally published version of this manuscript, an erroneous figure was published for Figure 5. This should read: Figure 5. instead of: Figure 5. The figure has been corrected in the article. © The Author(s) 2023. Published by Oxford University Press on behalf of Antibody Therapeutics. All rights reserved. For Permissions, please email: journals.permissions@oup.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/license s/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Antibody Therapeutics Oxford University Press

Correction: AB-Amy: machine learning aided amyloidogenic risk prediction of therapeutic antibody light chains

Antibody Therapeutics , Volume 6 (3): 1 – May 26, 2023

Loading next page...
 
/lp/oxford-university-press/correction-ab-amy-machine-learning-aided-amyloidogenic-risk-prediction-1EqIxmpiSw

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Oxford University Press
Copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of Antibody Therapeutics. All rights reserved. For Permissions, please email: journals.permissions@oup.com
eISSN
2516-4236
DOI
10.1093/abt/tbad012
Publisher site
See Article on Publisher Site

Abstract

Antibody Therapeutics, 2023, Vol. 6, No. 3 180 https://doi.org/10.1093/abt/tbad012 Advance Access Publication on 26 May 2023 Correction Correction: AB-Amy: machine learning aided amyloidogenic risk prediction of therapeutic antibody light chains This is a correction to: Yuwei Zhou and others, AB-Amy: machine learning aided amyloidogenic risk prediction of therapeutic antibody light chains, Antibody Therapeutics, 2023;, tbad007, https://doi.org/10.1093/abt/tbad007 In the originally published version of this manuscript, an erroneous figure was published for Figure 5. This should read: Figure 5. instead of: Figure 5. The figure has been corrected in the article. © The Author(s) 2023. Published by Oxford University Press on behalf of Antibody Therapeutics. All rights reserved. For Permissions, please email: journals.permissions@oup.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/license s/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

Journal

Antibody TherapeuticsOxford University Press

Published: May 26, 2023

There are no references for this article.